Neogen (NEOG) EPS (Weighted Average and Diluted) (2010 - 2026)
Neogen's quarterly EPS (Weighted Average and Diluted) came in at -$0.08 in Q1 2026, down 60.0% year-on-year from -$0.2 in Q1 2025, and down 14.29% quarter-over-quarter from -$0.07 in Q4 2025.
Neogen has reported EPS (Weighted Average and Diluted) for 17 years, with the latest figure at -$0.08 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 60.0% year-over-year to -$0.08; the trailing twelve-month figure through Feb 2026 stood at -$2.8 (down 25.56% YoY), and the FY2025 full-year result was -$5.03, down 12475.0% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.08, down from -$0.07 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.17 in Q3 2025, with the low at -$2.82 in Q2 2025.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.29, with a median of -$0.02 recorded in 2023.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 383.33% in 2025, while the deepest fall reached 14000.0% in 2025.
- Tracing NEOG's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.19 in 2022, then surged by 89.47% to -$0.02 in 2023, then plunged by 10400.0% to -$2.1 in 2024, then jumped by 96.67% to -$0.07 in 2025, then retreated by 14.29% to -$0.08 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.08 (Q1 2026), -$0.07 (Q4 2025), and $0.17 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | -0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -0.08 |
| Nov 30, 2025 | -0.07 |
| Aug 31, 2025 | 0.17 |
| May 31, 2025 | -2.82 |
| Feb 28, 2025 | -0.05 |
| Nov 30, 2024 | -2.10 |
| Aug 31, 2024 | -0.06 |
| May 31, 2024 | -0.02 |
| Feb 29, 2024 | -0.01 |
| Nov 30, 2023 | -0.02 |
| Aug 31, 2023 | 0.01 |
| May 31, 2023 | 0.04 |
| Feb 28, 2023 | 0.04 |
| Nov 30, 2022 | -0.19 |
| Aug 31, 2022 | 0.05 |
| May 31, 2022 | 0.14 |
| Feb 28, 2022 | 0.05 |
| Nov 30, 2021 | 0.10 |
| Aug 31, 2021 | 0.16 |
| May 31, 2021 | 0.15 |
| Feb 28, 2021 | 0.12 |
| Nov 30, 2020 | 0.15 |
| Aug 31, 2020 | 0.15 |
| May 31, 2020 | 0.15 |
| Feb 29, 2020 | 0.11 |
| Nov 30, 2019 | 0.15 |
| Aug 31, 2019 | 0.14 |
| May 31, 2019 | 0.30 |
| Feb 28, 2019 | 0.25 |
| Nov 30, 2018 | 0.31 |
| Aug 31, 2018 | 0.29 |
| May 31, 2018 | 0.33 |
| Feb 28, 2018 | 0.32 |
| Nov 30, 2017 | 0.33 |
| Aug 31, 2017 | 0.23 |
| May 31, 2017 | 0.24 |
| Feb 28, 2017 | 0.20 |
| Nov 30, 2016 | 0.22 |
| Aug 31, 2016 | 0.20 |
| May 31, 2016 | 0.26 |
| Feb 29, 2016 | 0.22 |
| Nov 30, 2015 | 0.24 |
| Aug 31, 2015 | 0.25 |
| May 31, 2015 | 0.25 |
| Feb 28, 2015 | 0.20 |
| Nov 30, 2014 | 0.21 |
| Aug 31, 2014 | 0.24 |
| May 31, 2014 | 0.20 |
| Feb 28, 2014 | 0.18 |
| Nov 30, 2013 | 0.17 |
| Aug 31, 2013 | 0.21 |
| May 31, 2013 | 0.19 |
| Feb 28, 2013 | 0.19 |
| Nov 30, 2012 | 0.18 |
| Aug 31, 2012 | 0.19 |
| May 31, 2012 | 0.25 |
| Feb 29, 2012 | 0.22 |
| Nov 30, 2011 | 0.22 |
| Aug 31, 2011 | 0.25 |
| May 31, 2011 | 0.25 |
| Feb 28, 2011 | 0.21 |
| Nov 30, 2010 | 0.26 |
| Aug 31, 2010 | 0.25 |